A drug safety group has delivered a positive analysis for a Sarepta Therapeutics-licensed RNA medicine, with the same study ...

Mortal Kombat 1 - Omni-Man and Tremor First Look ReactionEd Boon unveiled the new Omni-Man and Tremor Trailer at the ...

The local government here is turning its former quarantine center at the South Road Properties (SRP) into a temporary shelter ...

Ahmedabad: The Anti-Corruption Bureau (ACB) on Wednesday arrested assistant sub-inspector (ASI) Roshan Bhuriya of the State ...

Sarepta Therapeutics, Inc. (NASDAQ:SRPT), the leader in precision genetic medicine for rare diseases, today shared progress in the Phase 1/2 multiple ascending dose (MAD) clinical study of SRP-1003 ...

Arrowhead Pharmaceuticals, Inc. (NASDAQ: ARWR) today announced that it has earned a $200 million milestone payment from Sarepta Therapeutics (NASDAQ: SRPT). The milestone was earned when Arrowhead ...

SRP says varying releases will continue for the next few weeks to balance the water supply between the reservoirs after ...

Two minority owners are suing Phoenix Suns and Mercury majority owner Mat Ishbia, claiming mismanagement and fraud. The suit ...

Highland Park is located in the town of Kirkwall in Orkney, the northernmost part of Scotland that is at the same latitude as ...

Learn more about whether Immunocore Holdings plc or Sarepta Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

A Phase 1/2 clinical trial testing SRP-1003 for myotonic dystrophy type 1 is progressing with higher doses as planned.